Antiprotozoal activity profiling of approved drugs: a starting point toward drug repositioning. DNDi data is made available herewith freely to third parties. Use of these data anywhere in the world is therefore not subject to any licensing terms.

Type
Data/Reagent

A set of 100 registered drugs with drug repositioning potential for neglected diseases was assembled and tested in vitro against four protozoan parasites.

Disease
Malaria
Chagas disease
Human African trypanosomiasis (HAT)
Leishmaniasis
Research areas
Basic research
Condition of use

n/a

IP information

Antiprotozoal activity profiling of approved drugs: a starting point toward drug repositioning. Marcel Kaiser*, Pascal Mäser, Leela Pavan Tadoori, Jean-Robert Ioset, Reto Brun. PLOS ONE 10 8 : e0135556. doi:10.1371/journal.pone.0135556